2.0 tirzepatide starting dose Dosing for Weight Loss in Units Tirzepatide Dosage Chart 2026: Mounjaro
Description
PMID: 9683204
Following an FDA nod for oral Wegovy in December 2025, alternatives now cater to individuals preferring tablets over injections
The key takeaway here is that as long as the medication is administered correctly, either site should work well for weight loss or diabetes management
It is important to always consult with your healthcare provider if you experience any unexpected or concerning side effects
A non-head-to-head comparison of outcomes (SURMOUNT-1 versus STEP-1): tirzepatide 15 mg produced an average of 20.9% weight loss at 72 weeks in SURMOUNT-1 (n=2,539)
